Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression
Status:
Unknown status
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to identification of genetic markers and predictors of
antidepressant-induced suicidality in youth depression. Participants who take the
standardized pharmacotherapy (bupropion or lamotrigine) for depression will be observed for 8
weeks. They will do several scales and genetic tests at visit 1 (week 0), visit 3 (week 4)
and visit 4 (week 8)